Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Divergent Regulation of Dihydrofolate Reductase Between Malaria Parasite and Human Host
Kai Zhang,Pradipsinh K. Rathod*
For half a century, successful antifolate therapy
against Plasmodium falciparum malaria has been attributed to
host-parasitedifferences in drug binding to dihydrofolate
reductase-thymidylatesynthase (DHFR-TS). Selectivity may also arise
through previouslyunappreciated differences in regulation of this drug
target. TheDHFR-TS of Plasmodium binds its cognate
messenger RNA (mRNA) andinhibits its own translation. However, unlike
translational regulationof DHFR or TS in humans, DHFR-TS mRNA binding
is not coupled toenzyme active sites. Thus, antifolate treatment does
not relievetranslational inhibition and parasites cannot replenish
dead enzyme.
Department of Chemistry, University of Washington, Seattle, WA
98195, USA, and Seattle Biomedical Research Institute, Seattle, WA
98109, USA.
*
To whom correspondence should be addressed. E-mail:
rathod{at}chem.washington.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Daniel E. Goldberg (19 April 2002) Science296 (5567), 482.
[DOI: 10.1126/science.1071206] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Species-Specific Differences in Translational Regulation of Dihydrofolate Reductase.
Y.-C. Hsieh, N. E. Skacel, N. Bansal, K. W. Scotto, D. Banerjee, J. R. Bertino, and E. E. Abali (2009)
Mol. Pharmacol.
76, 723-733
|Abstract »|Full Text »|PDF »
The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Crystal structure of dihydrofolate reductase from Plasmodium vivax: Pyrimethamine displacement linked with mutation-induced resistance.
P. Kongsaeree, P. Khongsuk, U. Leartsakulpanich, P. Chitnumsub, B. Tarnchompoo, M. D. Walkinshaw, and Y. Yuthavong (2005)
PNAS
102, 13046-13051
|Abstract »|Full Text »|PDF »
High-throughput Screening for Potent and Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase.
J. Baldwin, C. H. Michnoff, N. A. Malmquist, J. White, M. G. Roth, P. K. Rathod, and M. A. Phillips (2005)
J. Biol. Chem.
280, 21847-21853
|Abstract »|Full Text »|PDF »
Mechanisms of Resistance of Malaria Parasites to Antifolates.
Developmental Regulation of dUTPase in Drosophila melanogaster.
A. Bekesi, I. Zagyva, E. Hunyadi-Gulyas, V. Pongracz, J. Kovari, A. O. Nagy, A. Erdei, K. F. Medzihradszky, and B. G. Vertessy (2004)
J. Biol. Chem.
279, 22362-22370
|Abstract »|Full Text »|PDF »
Kinetic Characterization of Bifunctional Thymidylate Synthase-Dihydrofolate Reductase (TS-DHFR) from Cryptosporidium hominis: A PARADIGM SHIFT FOR TS ACTIVITY AND CHANNELING BEHAVIOR.
Prediction of RNA-binding proteins from primary sequence by a support vector machine approach.
L. Y. HAN, C. Z. CAI, S. L. LO, M. C.M. CHUNG, and Y. Z. CHEN (2004)
RNA
10, 355-368
|Abstract »|Full Text »|PDF »
Chloroquine Resistance Modulated in Vitro by Expression Levels of the Plasmodium falciparum Chloroquine Resistance Transporter.
K. L. Waller, R. A. Muhle, L. M. Ursos, P. Horrocks, D. Verdier-Pinard, A. B. S. Sidhu, H. Fujioka, P. D. Roepe, and D. A. Fidock (2003)
J. Biol. Chem.
278, 33593-33601
|Abstract »|Full Text »|PDF »
Glucosamine Inhibits Inositol Acylation of the Glycosylphosphatidylinositol Anchors in Intraerythrocytic Plasmodium falciparum.
R. S. Naik, G. Krishnegowda, and D. C. Gowda (2003)
J. Biol. Chem.
278, 2036-2042
|Abstract »|Full Text »|PDF »